导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 19.80% | 204/1050 |
| 近一周 | -1.94% | 380/1104 |
| 近一月 | -7.74% | 893/1102 |
| 近一季 | -11.00% | 715/1092 |
| 近半年 | 8.39% | 265/1070 |
| 近一年 | 23.58% | 200/1018 |
| 近两年 | 76.40% | 317/926 |
| 近三年 | 30.87% | 388/834 |
| 成立以来 | 315.80% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.27% 246/1070 |
50.66% 227/1101 |
- - |
- - |
| 2025 | 21.63% 636/1065 |
2.23% 628/1014 |
-1.64% 822/1038 |
23.89% 485/1050 |
-2.36% 582/1065 |
| 2024 | -1.34% 621/1011 |
-6.79% 651/960 |
-2.81% 494/983 |
13.70% 327/991 |
-4.21% 606/1011 |
| 2023 | -22.09% 726/952 |
5.37% 303/880 |
-9.83% 763/895 |
-10.62% 605/915 |
-8.25% 779/952 |
| 2022 | -18.46% 276/867 |
-21.90% 632/773 |
10.87% 232/806 |
-12.52% 429/845 |
7.65% 122/867 |
| 2021 | -8.49% 469/740 |
-6.99% 418/580 |
18.40% 181/659 |
-14.77% 605/704 |
-2.51% 531/740 |
| 2020 | 76.59% 107/554 |
6.68% 58/419 |
33.55% 85/466 |
8.62% 283/517 |
14.11% 224/554 |
| 2019 | 76.74% 16/410 |
30.90% 325/1149 |
8.31% 21/1231 |
12.29% 74/390 |
11.01% 135/410 |
| 2018 | -20.15% 82/349 |
- - |
- - |
- - |
-14.29% 840/1080 |
| 2017 | 46.91% 8/285 |
- - |
- - |
- - |
- - |
| 2016 | -7.71% 60/205 |
- - |
- - |
- - |
- - |
| 2015 | 56.78% 16/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 嘉实新兴产业股票 VS. 东吴新产业精选股票A(580008) |